Sign Out
Advise patients of the need for periodic monitoring of serum potassium levels. Advise patients receiving Firialta to consult with their physician before using potassium supplements or salt substitutes containing potassium [see Hyperkalemia under Precautions].
Advise patients to avoid strong or moderate CYP3A4 inducers and to find alternative medicinal products with no or weak potential to induce CYP3A4 [see CYP3A4 Inhibitors and Inducers under Interactions].
Avoid concomitant intake of grapefruit or grapefruit juice as it is expected to increase the plasma concentration of finerenone [see CYP3A4 Inhibitors and Inducers under Interactions].
Advise women that breastfeeding is not recommended at the time of treatment with Firialta and for 1 day after treatment [see Lactation under Use in Pregnancy & Lactation].
